ALEMTUZUMAB INDUCTION IN PANCREAS TRANSPLANTATION

ALEMTUZUMAB INDUCTION IN PANCREAS TRANSPLANTATION

Bibliografske podrobnosti
Main Authors:	Muthusamy, A, Vaidya, A, Sinha, S, Quiroga, I, Reddy, S, Gilbert, J, Friend, P
Format:	Journal article
Izdano:	2011

Podobne knjige/članki

Alemtuzumab induction and steroid free immunosupprssion in pancreas transplantation.
od: Muthusamy, A, et al.
Izdano: (2007)

Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.
od: Muthusamy, A, et al.
Izdano: (2008)

Steroid-free immunosuppression in pancreas transplantation using Alemtuzumab induction
od: Muthusamy, A, et al.
Izdano: (2007)

SINGLE CENTRE EXPERIENCE WITH DCD PANCREAS TRANSPLANTATION
od: Muthusamy, A, et al.
Izdano: (2011)

PANCREAS TRANSPLANTATION IN RECIPIENTS AGED >= 50 YEARS
od: Muthusamy, A, et al.
Izdano: (2011)

Campath Induction and Steroid Avoidance in Pancreas Transplantation - A Single Centre Experience in 231 Patients.
od: Muthusamy, A, et al.
Izdano: (2009)

Complex arterial reconstruction for pancreas transplantation in recipients with advanced arteriosclerosis.
od: Muthusamy, A, et al.
Izdano: (2008)

Expanded criteria donors in pancreas transplantation: The Oxford experience
od: Muthusamy, A, et al.
Izdano: (2009)

Revascularization of the gastro-epiploic artery in pancreas transplant.
od: Muthusamy, A, et al.
Izdano: (2008)

Clopidogrel-associated acute migratory arthritis following kidney-pancreas transplantation.
od: Muthusamy, A, et al.
Izdano: (2006)

Thromboelastography directed anticoagulation in pancreas transplantation
od: Muthusamy, A, et al.
Izdano: (2007)

PANCREAS ALLOGRAFT: IMPACT OF THE RETRIEVAL CENTRE ON THE UTILIZATION OF THE ORGAN
od: Rizzello, A, et al.
Izdano: (2011)

Value of Magnetic Resonance Angiography in Pancreas Transplantation.
od: Suh, N, et al.
Izdano: (2009)

Simultaneous pancreas--kidney transplantation: to anticoagulate or not? Is that a question?
od: Vaidya, A, et al.
Izdano: (2007)

Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.
od: Plata-Munoz, J, et al.
Izdano: (2009)

Pancreas transplantation: past, present, future
od: Dholakia, S, et al.
Izdano: (2016)

Simultaneous pancreas kidney transplantation in the HIV-positive patient.
od: Akhtar, M, et al.
Izdano: (2011)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
od: Haynes, R, et al.
Izdano: (2014)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
od: Haynes, R, et al.
Izdano: (2014)

Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
od: Haynes, R, et al.
Izdano: (2014)

Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.
od: Flechner, S, et al.
Izdano: (2005)

Donors after circulatory death pancreas transplantation
od: Mittal, S, et al.
Izdano: (2017)

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
od: Watson, C, et al.
Izdano: (2005)

Pancreas transplantation
od: Knight, S, et al.
Izdano: (2017)

Pancreas transplantation from non-heart beating donors in the United Kingdom
od: Muthusamy, A, et al.
Izdano: (2009)

PANCREAS TRANSPLANTATION FROM NON-HEART BEATING DONORS IN THE UNITED KINGDOM
od: Muthusamy, A, et al.
Izdano: (2009)

Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.
od: Morgan, R, et al.
Izdano: (2012)

Alemtuzumab and sirolimus in renal transplantation: six-year results of a single-arm prospective pilot study.
od: Sutherland, A, et al.
Izdano: (2014)

Risk analysis for deterioration of renal function after pancreas alone transplant.
od: Chatzizacharias, N, et al.
Izdano: (2012)

ANALYSIS OF RENAL FUNCTION AFTER SOLITARY PANCREAS TRANSPLANTATION: IS CNIs THE ONLY CULPRIT?
od: Chatzizacharias, N, et al.
Izdano: (2011)

Alemtuzumab: right drug, right dose?
od: Haynes, R, et al.
Izdano: (2011)

Pancreas allograft thrombosis following intravenous immunoglobulin administration to treat parvovirus B19 infection.
od: Muthusamy, A, et al.
Izdano: (2009)

Pancreas allograft thrombosis.
od: Muthusamy, A, et al.
Izdano: (2010)

Renal function in type 1 diabetics one year after successful pancreas transplantation.
od: Chatzizacharias, N, et al.
Izdano: (2011)

Systematic reviews of alemtuzumab in renal transplantation.
od: O'Callaghan, J, et al.
Izdano: (2013)

Systematic reviews of alemtuzumab in renal transplantation
od: O'Callaghan, J, et al.
Izdano: (2013)

Pancreas transplantation from donors after circulatory death from the United Kingdom.
od: Muthusamy, A, et al.
Izdano: (2012)

Challenges in pancreas transplantation
od: Sharples, E, et al.
Izdano: (2016)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
od: Masashi Furukawa, et al.
Izdano: (2022-06-01)

Preliminary Data on the Renal Function after Pancreas Transplant in Type 1 Diabetics with Borderline EGFR
od: Chatzizacharias, N, et al.
Izdano: (2010)